Realising the value of wellness
Leadership of the medtech/healthtech sector – With enhanced diagnostics, early detection, better understanding of disease causation and progression, when will the balance shift in favour of healthtech over biotech?
FACILITATED BY
PHIL PACKER | Innovation Lead AMR and Vaccines | Innovate UK
PANELLISTS
NINA SKORYTCHENKO | Co-founder & Chief Executive Officer | Avenna
JUHI TANDON | Clinical Director | Cognitant
DORIS-ANN WILLIAMS MBE | Chief Executive | BIVDA
JOANNA WIECEK | Chief Scientific Officer | CircaGene
TILL BACHMANN | Professor of Molecular Diagnostics and Infection | The University of Edinburgh
JANE FREEMAN | Professor of Molecular Diagnostics and Infection | The University of Edinburgh